BBC News – A kidney cancer patient who was refused a life-saving drug on the NHS has been given hope, after a mystery benefactor offered to pay for the treatment. After his plight was highlighted by a cancer campaign group, a US hedge fund manager has come forward to help.
Despite being told by doctors that Sutent could lengthen his life, the National Institute for Health and Clinical Excellence (Nice) has said the drug is not cost effective, so PCTs are not obliged to prescribe it on the NHS.
After hearing his story, an anonymous New York hedge fund manager contacted the British cancer campaign group, the Pamela Northcott fund, which told Mr Rosser of the offer.
